Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
P wave duration and dispersion and QT interval in multiple sclerosis.
Detection of postural sway abnormalities by wireless inertial sensors in minimally disabled patients with multiple sclerosis: a case-control study.
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Quantifying progression of multiple sclerosis via classification of depth videos.
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Update in pediatric optic neuritis.
The fumaric acid ester BG-12: a new option in MS therapy.
Chronic illness and return to work: a social cognitive perspective.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
The health promotion work of the district nurse: interpreting its embeddedness.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Hospitalization rates and discharge status in multiple sclerosis.
Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Quality of life among people with multiple sclerosis: Replication of a three-factor prediction model.
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation.
Most Scottish neurologists do not apply the 2010 McDonald criteria when diagnosing multiple sclerosis.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait.

Pages